To find out more, researchers from Novo Nordisk and Market Track LLC, a market research company, conducted a survey of 550 people in the US (average age 53 years, 86% female) who were taking semaglutide for weight loss
The semaglutide component is the same molecule at the same doses, so the weight loss outcomes are expected to be comparable
Main Points Retatrutide is a triple-action peptide that targets three receptor pathways involved in blood sugar control, appetite regulation, and metabolism
When asking about Mounjaro vs Trulicity , Mounjaro generally shows better results for both blood sugar reduction and weight loss due to its dual hormone mechanism
We also sent a verification text
Or does the drug directly impact cancer cells